Literature DB >> 1973937

Neuroendocrine effects of azapirones.

P J Cowen1, I M Anderson, D G Grahame-Smith.   

Abstract

In healthy volunteers, the azapirones--buspirone, ipsapirone, and gepirone--increase plasma cortisol and decrease body temperature; buspirone and gepirone also increase plasma prolactin and growth hormone. Data from animal studies suggest that the ability of azapirones to decrease body temperature and increase corticotropin and corticosterone is mediated by stimulation of presynaptic and postsynaptic serotonin (5-hydroxytryptamine, 5-HT) type 1A subtype receptors, respectively. The mechanism of altered growth hormone and prolactin secretion is less clear. While animal studies implicate changes in dopamine function, current human investigations suggest that 5-HT1A receptors also may be involved in these endocrine responses. Further investigations, using more selective 5-HT receptor antagonists, will be required to resolve this issue.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973937     DOI: 10.1097/00004714-199006001-00005

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  13 in total

1.  Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers.

Authors:  I M Anderson; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Lithium and 5-HT1A receptor sensitivity: a neuroendocrine study in healthy volunteers.

Authors:  A E Walsh; C J Ware; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  PERSONALITY FACTOR CORRELATES OF GROWTH HORMONE AND HYPOTHERMIC RESPONSE TO BUSPIRONE CHALLENGE IN SUICIDAL SOLDIERS.

Authors:  Msvk Raju; M K Garg; B Rajguru; K Srivastava
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder.

Authors:  K P Lesch; A Hoh; H M Schulte; M Osterheider; T Müller
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Neuroendocrine effects of sumatriptan.

Authors:  J R Herdman; N J Delva; R E Hockney; G M Campling; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

Review 6.  The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?

Authors:  G G Kinney; M T Taber; V K Gribkoff
Journal:  Mol Neurobiol       Date:  2000-06       Impact factor: 5.590

7.  Effect of pindolol on hormone secretion and body temperature: partial agonist effects.

Authors:  H Y Meltzer; M Maes
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

8.  Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.

Authors:  I Berlin; S Chalon; C Payan; G Schöllnhammer; F Cesselin; O Varoquaux; A J Puech
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

9.  Buspirone does not produce a 5-HT1A-mediated decrease in temperature in man.

Authors:  H S Lee; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

10.  Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man.

Authors:  H Y Meltzer; M Maes
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.